An Introduction to Forensic Toxicology
|
|
- Norman Higgins
- 6 years ago
- Views:
Transcription
1 An Introduction to Forensic Toxicology Jennifer Shea, PhD, FCACB Ken Obenson, MBBS MFFLM (UK) FRCPC (Anat) FRCPC (Forensic Path) Dip American Brd of Path (Anat & Clin/Cytopath/Forensic Path) April 11, 2015
2 What is forensic toxicology? Sample collection What testing is done? Volatile Screen Broad Spectrum Drug Screen Targeted Drug Testing Biochemical Analysis Interpreting Results General Considerations Outline
3 Toxicology is the study of the adverse effects of drugs and chemicals on biological systems Forensic toxicology is the application of toxicology for the purposes of the law Four disciplines: 1. Postmortem Toxicology 2. Human Performance Toxicology 3. Doping Control 4. Workplace Drug Testing What is Forensic Toxicology?
4 Work with coroners and pathologists to help establish the role of alcohol, drugs, and poisons in the cause of death Identify and quantify the presence of drugs and chemicals in blood and other specimens Provide advice regarding result interpretation Drug kinetics and interactions Metabolism Drug tolerance Postmortem artifacts Drug stability Postmortem Toxicology
5 For every case, pathologists should collect: Preserved blood Vitreous humor Urine (if available) Other tissues are sometimes useful depending on the nature of the case and what specimens from the list above are available: Liver Bile Stomach Contents Sample Collection: The Basics
6 Whole Blood Two FULL preserved (grey top) vacutainers (minimum 10 ml required) Preservative (NaF) prevents bacterial activity that may cause postmortem alcohol formation Preservative prevents degradation of drugs (eg cocaine) by enzymes in blood Vacutainers should be full to prevent loss of volatile substances (eg. alcohol) to air space above sample Blood obtained from the femoral vein is preferred due to the potential for postmortem drug redistribution if collected from other sites Blood should be kept at 4 C (up to one week) until sent to the toxicology laboratory Sample Collection: The Basics
7 Postmortem Drug Redistribution (PMR) Property of chemical make up of drug, volume of distribution, etc Some drugs are sequestered in tissues; very little freely circulates in blood After death, significant amounts of drug can be released from tissues (eg heart, liver, lungs) which falsely elevates blood concentration in vessels associated with these organs Tricyclic antidepressants are the classic example of drugs undergoing PMR however many reports of other drugs as well PMR may be related to the postmortem interval as well Sample Collection: The Basics
8 Postmortem Drug Redistribution: Case Reports Anatomic Location Femoral /Subclavian Time of Collection At scene Autopsy* Blood Fentanyl Concentration Case 1: 19 ng/ml Case 2: 18 ng/ml Case 1: 15 ng/ml Case 2: 39 ng/ml Heart Autopsy* Case 1: 22 ng/ml (Ratio = 1.5) Case 2: 46 ng/ml (Ratio = 1.2) Adapted from J Forensic Sci. 2014;59(5): *Autopsy occurred on average 18.8 hours after blood draw at scene. Sample Collection: The Basics
9 Urine Two preservative free (red top) vacutainers. Preserved vacutainers also acceptable. Urine may be used as a screening tool when required. Drugs/metabolites typically present in higher concentrations and remain for days after use Vitreous Humour Preservative free vacutainer. Preserved vacutainer also acceptable except when requesting electrolytes Sodium in preservative interferes with Na result Sample Collection: The Basics
10 Liver Tissue Preservative free plastic specimen container. Minimum 10 grams required. Most drugs metabolized in liver. May be useful when blood unavailable. Bile Fluid Preservative free vacutainer or plastic specimen container. Gastric contents Preservative free vacutainer or plastic specimen container. Note: Minimal data available to interpret drug concentrations in these specimen types (esp. stomach contents and bile fluid). Consult with toxicologist if testing is required. Sample Collection: Additional Specimens
11 In general, perform three different screens: 1. Alcohol analysis 2. Broad spectrum drug screen 3. Biochemical analyses (aids in identification of diabetes, kidney disease, diabetic/alcoholic ketoacidosis, etc) *Targeted drug testing available upon request (for most drugs) What type of testing is done?
12 Specimen Tests Routinely Performed Volatile screen (ethanol, methanol, isopropanol, acetone) BLOOD HbA1c (marker of diabetes) Broad Spectrum Drug Screen (includes amphetamines, anticonvulsants, antidepressants, antihistamines, antipsychotics, barbiturates, benzodiazepines, cannabinoids, CNS stimulants, cocaine and metabolites, hallucinogens, hypnosedatives, hypoglycemics, muscle relaxants, NSAIDs, opiates/opiods, salicylates) What type of testing is done?
13 Specimen VITREOUS HUMOR Tests Routinely Performed Volatile screen (ethanol, methanol, isopropanol, acetone) Glucose (marker of diabetes) Beta-hydroxybutyrate (marker of ketoacidosis) URINE OTHER (liver, bile, stomach contents, etc) Urea and creatinine (marker of kidney function) Used for screening purposes when required. Screen includes the same list of drugs as blood. Not routinely tested unless required for interpretation. When testing of a specific drug or group of drugs in these specimens is required, please contact the toxicologist to discuss. What type of testing is done?
14 Screens and (if present) quantitates four volatile substances using head space GC-FID analysis 1. Ethanol One of the most commonly abused drugs 2. Methanol Common solvent used in industrial and clinical labs 3. Acetone Ketone body produced during carbohydrate deprivation (eg. alcoholic/diabetic ketoacidosis) 4. Isopropanol Rubbing alcohol. May also be produced by acetone metabolism. Toxicology Testing: Volatile Screen
15 Death due to ethanol ingestion may be the result of: Acute ingestion Alcoholic ketoacidosis Ethanol in combination with other drugs Consumption of large amounts of ethanol results in respiratory and CNS depression in a dose-dependent manner < 50 mg/dl generally considered insignificant > mg/dl may result in coma >350 mg/dl possible death from respiratory arrest These thresholds are general guidelines. Limits may be lowered when other drugs are present. Toxicology Testing: Ethanol
16 Caveats associated with interpreting ethanol concentrations: 1. Postmortem Formation Up to 100 mg/dl ethanol (and even higher in some case reports) can be formed in blood due to fermentation of substrates (eg. glucose) in the presence of bacteria (eg. decomposed body). Ethanol also measured in vitreous humor or urine; protected fluid therefore more resistant to postmortem ethanol formation If ethanol present in blood but not vitreous, suspect postmortem formation 2. Tolerance Dispositional/Metabolic Altered absorption, distribution or elimination due to repeated ethanol use Cellular Altered pharmacological response to ethanol Toxicology Testing: Ethanol
17 Screen performed on all blood samples received using immunoassay and mass spectrometry (LC/TOF-MS) All positive results are confirmed and quantitated using a variety of analytical techniques (GC-MS, GC-MS/MS, LC-MS/MS) > 300 drugs included in screen If you want to know if a particular drug is included, call the toxicologist. Commonly encountered drugs include opiates/opioids (codeine, morphine, methadone, fentanyl), antidepessants, stimulants (cocaine, amphetamine/methamphetamine), other therapeutic medications Toxicology Testing: Broad Spectrum Drug Screen
18 Next to alcohol, most common postmortem tox finding Opiate = Naturally occuring alkaloid analgesic (eg. morphine and codeine) Opioid = Opiates + synthetic and semi-synthetic alkaloids whose pharmacological effects mimic morphine (eg. heroin, fentanyl, methadone, etc) Morphine Codeine Heroin Fentanyl Methadone Toxicology Testing: Opiates/Opioids
19 Opiates/opioids elicit their effects by binding to opioid receptors within the central and peripheral nervous system as well as GI tract Therapeutic Effects: Mainly used for pain relief (acute and chronic) Side Effects: CNS and respiratory depression, sedation, euphoria, constipation, nausea/vomiting, euphoria Additive effects with alcohol on CNS and respiratory depression Codeine < Morphine/Methadone < Heroin << Fentanyl Toxicology Testing: Opiates/Opioids
20 Tolerance is very important to consider when interpreting opioid results Best demonstrated by looking at therapeutic, toxic, and fatal ranges for methadone Therapeutic (ng/ml) In 16 drug related fatalities, mean postmortem methadone concentration was 700 ng/ml (range 110 1,310 ng/ml) In 35 non-drug related deaths, the mean postmortem methadone concentration was 640 ng/ml (range 100 4,260 ng/ml) It is almost impossible to interpret methadone results without usage history Toxicology Testing: Opiates/Opioids Toxic (ng/ml) Fatal (ng/ml) Approx Approx Approx. >300
21 Benzodiazepines (eg. diazepam, clonazepam, etc) One of the most widely prescribed drugs CNS depressants anxiolytics, anticonvulsants, muscle relaxants Rarely result in fatality unless combined with other drugs Cannabinoids Delta-9 THC is primary active metabolite Metabolites may be present in urine for many days (up to 20 days in chronic smokers) Diazepam Delta-9 THC Toxicology Testing: Other common drugs
22 Stimulants (eg. cocaine, amphetamine, methamphetamine) Not as commonly observed in postmortem cases in NB Concomitant use of alcohol and cocaine can result in production of a toxic metabolite, cocaethylene Antidepressants (eg. amitriptyline, sertraline, venlafaxine, citalopram, etc) Very common to detect antidepressant(s) on postmortem toxicology, either as incidental finding or related to an overdose Most subject to PMR interpret with caution if central blood used for analysis Cocaine Amitriptyline Toxicology Testing: Other common drugs
23 No single analytical technique can detect all drugs Not all drugs are part of broad spectrum drug screen Targeted drug testing can be done for some newer drugs (eg. bath salts, synthetic cannabinoids) or those less frequently encountered (eg. poisons such as CO) Important to provide case history with all toxicology requests! Methodology used depends largely on the drug s chemical structure. GC-MS, GC-MS/MS, LC-MS/MS, etc Toxicology Testing: Targeted Drug Testing
24 Laboratory also performs routine biochemical analyses on specimens as an adjunct to toxicology testing Vitreous humor is best specimen for most biochemical testing as blood is usually hemolysed which may interfere with analytical methodologies Exception: HbA1c in whole blood Biochemical testing aids in identification of undiagnosed or poorly controlled diabetes (VH glucose, WB HbA1c), diabetic ketoacidosis (VH β-oh, glucose) and kidney function (VH creatinine, urea) Toxicology Testing: Biochemical Analyses
25 Diabetes is a disease characterized by hyperglycemia Complications are classified as chronic (nephropathy, retinopathy, neuropathy) and acute (diabetic ketoacidosis) Estimated that 1 million have the disease but do not know it Biochemical Analyses: Diabetes Public Health Agency of Canada, 2011 Canadian Diabetes Association
26 Insufficient cellular glucose to maintain energy stores Adipose tissue breaks down fatty acids Liver converts fatty acids to ketone bodies as alternative energy source: Beta-hydroxybutyrate Acetoacetate Acetone Liver also breaks down glycogen into glucose END RESULT: DKA GLUCOSE and KETONE BODIES ph (metabolic acidosis)
27 Extremely difficult to interpret post-mortem blood glucose Continuous consumption of glucose by surviving cells and bacteria post-mortem Glucose almost always undetectable in blood Blood glucose rarely measured in forensic chemistry Vitreous humor is better preserved after death making it a better specimen choice High VH glucose suggestive of high plasma glucose at time of death Caveats with VH glucose testing: Ongoing metabolism occurs in VH too so will also see drop postmortem Low VH glucose Hypoglycemia Biochemical Analyses: Blood vs Vitreous Humor Glucose
28 β-hydroxybutyrate (βhb) Ketone body produced during ketoacidosis Measured in vitreous humor Can help elucidate chronic hyperglycemia from acute diabetic ketoacidosis (>3 mmol/l generally indicative of ketoacidosis) HbA1c Formed through non-enzymatic addition of glucose to N-terminal valine of β chain of Hb Marker of longer term (~3 mth) glycemic control Reflects metabolic state of the deceased in the weeks prior to death More stable than glucose in blood (internal studies show stability up to 6 mth) Can support other findings including elevated glucose and βhb HbA1c 6.5% consistent with diabetes Biochemical Analyses: Other Markers of Diabetes
29 Evidence of drug overdose or non-compliance with prescribed medication? State of body on discovery Decomposition may result in decreased (stability) or increased (PMR) drug levels Postmortem formation of ethanol Source of blood (central vs peripheral)? Tolerance to drugs detected in blood? Opiates/opioids Ethanol Interpreting Results: General Considerations
30 Forensic toxicology can aid pathologists and coroners in elucidating the cause and manner of death Proper specimen collection is vital to obtaining meaningful toxicology results Preserved vacutainers help maintain specimen integrity of blood samples Peripheral (femoral) blood is always preferred over a central source A case history (including medication summary) and/or preliminary autopsy findings can greatly aid the toxicologist Can aid with interpretation of drug levels where tolerance is important Can help determine need for additional testing above and beyond general drug screen When in doubt, call the toxicologist! Summary
31 Please contact me with any questions. Phone: Thank you!
What Can Dead People Tell Us? Postmortem Toxicology for Attorneys
What Can Dead People Tell Us? Postmortem Toxicology for Attorneys Dr. Allison A. Muller Diplomate, American Board of Applied Toxicology Principal/Owner: Acri Muller Consulting, LLC Learning objectives
More informationPain Management Drug Testing: A Laboratory Perspective
Ernest Jimenez III, M.T.(ASCP) Nothing to declare. Laboratory manager at Pharos Diagnostics, LLC., located in Tucson, AZ. Pain Management Drug Testing: A Laboratory Perspective 1 2 Pain Management Drug
More informationSt. Louis University Forensic Toxicology Laboratory
St. Louis University Forensic Toxicology Laboratory Specimen Collection Guidelines Postmortem Forensic Toxicology Sample Collection Guidelines Scope The provides comprehensive analysis of general unknowns
More informationAll substances are poisons: there is none which is not a poison. The right dose differentiates a poison and a remedy. (Paraclesus, )
All substances are poisons: there is none which is not a poison. The right dose differentiates a poison and a remedy (Paraclesus, 1493-1541) Discussion Questions About Paraclesus Quote 1. Do you agree
More informationUrine Drug Testing. Methadone/Buprenorphine 101 Workshop. Ron Joe, MD, DABAM December 10, 2016
Urine Drug Testing Methadone/Buprenorphine 101 Workshop Ron Joe, MD, DABAM December 10, 2016 Learning objectives Clarify the purpose of urine drug testing (UDT) Distinguish between UDT for detection of
More informationEffective Date: Approved by: Laboratory Executive Director, Ed Hughes (electronic signature)
1 Policy #: 803 (PLH-803-02) Effective Date: NA Reviewed Date: 4/11/2008 Subject: URINE DRUG SCREENS Approved by: Laboratory Executive Director, Ed Hughes (electronic signature) Approved by: Laboratory
More informationLearning Objectives. Drug Testing 10/17/2012. Utilization of the urine drug screen: The good, the bad, and the ugly
Utilization of the urine drug screen: The good, the bad, and the ugly Jennifer A. Lowry, MD Chief, Section of Medical Toxicology Children s Mercy Hospital Kansas City, MO Learning Objectives Describe the
More informationIntroduction to Postmortem Studies in Forensic Pathology
Introduction to Postmortem Studies in Forensic Pathology Objectives Compare and contrast a forensic autopsy versus a medical autopsy. Describe different types of evidentiary specimen collection in forensic
More informationFORENSIC TOXICOLOGY SERVICE
Accredited Medical Laboratory, Reference No: 0814 FORENSIC TOXICOLOGY SERVICE LEICESTER ROYAL INFIRMARY USER HANDBOOK 2016-17 1 of 12 CONTENTS Contacts and normal laboratory hours 3 Our services 4 Specimen
More informationLyndsey Knoy, D-ABFT-FT Forensic Scientist Washington State Toxicology Laboratory.
Lyndsey Knoy, D-ABFT-FT Forensic Scientist Washington State Toxicology Laboratory Lyndsey.Knoy@wsp.wa.gov Forensic Toxicology is an interdisciplinary science that analyzes blood, fluid and/or tissues for
More informationCross-reactivity reactivity in EMIT
Blood Drug Analysis at the State Bureau of Investigation Crime Laboratory Richard W. Waggoner, Jr. Sample Requirements 2-10 ml gray top vacutainers At least 10 ml of urine sample for drug facilitated sexual
More informationBell-Ringer. Forensic Science
Bell-Ringer Forensic Science Looking for Toxins Forensic Toxicology Part 2 Toxins Most poisons don t cause visible changes to the body neither in a living person nor during an autopsy. Some do, but most
More informationTesting for Controlled Substances
Testing for illicit drugs Testing for Controlled Substances 1 Purposes: Employment Sports Screening medical eval. Legal Monitoring Treatment Probation Prescribing controlled substances Forensics 2 Drug
More informationLaboratory Testing to Support Pain Management: Methods, Concepts and Case Studies
Laboratory Testing to Support Pain Management: Methods, Concepts and Case Studies Frederick G. Strathmann, PhD, DABCC, (CC,TC) Medical Director, Toxicology Associate Scientific Director of MS ARUP Laboratories
More informationDrug Profiles of Apprehended Drivers in Victoria
Drug Profiles of Apprehended Drivers in Victoria J Gerostamoulos, P McCaffrey, O H. Drummer and M Odell*. Victorian Institute of Forensic Medicine, Department of Forensic Medicine, Monash University, 57-83
More informationEDUCATIONAL COMMENTARY rd TEST EVENT Chemistry Urine Drug Testing
EDUCATIONAL COMMENTARY 2003 3 rd TEST EVENT Chemistry Urine Drug Testing Educational commentary is provided through our affiliation with the American Society for Clinical Pathology (ASCP). To obtain FREE
More informationCutoff levels for hydrocodone in a blood test
Cutoff levels for hydrocodone in a blood test The premier DNA and drug testing company in the North Texas area. Specializing in legal cases but also provide testing for employers and private individuals.
More informationForensic Toxicology Scope of Testing and Detection Limits
Forensic Toxicology Scope of Testing and Detection Limits Table of Contents QUALITATIVE ANALYSES... 2 Volatile Screen by GC/FID... 2 Carbon Monoxide by Microdiffusion... 2 Ethylene Glycol by GC/MS... 2
More informationAlcohol. Ethanol Highlands Parkway, Suite 100 Smyrna, GA 30082
Alcohol The alcohol of interest is ethanol. Ethanol has a sedative effect in the brain. Ethanol intoxication symptoms include blurred vision, slurred speech, poor coordination and difficulty thinking depending
More informationProcedure for Toxicology Analysis Version 7 Toxicology Unit Effective Date: 03/14/2014 Issued by Drug Chemistry Forensic Scientist Manager
Toxicology Analysis 1.0 Purpose - This procedure specifies the required elements for analyzing toxicology submissions and reporting drug testing results. 2.0 Scope This procedure applies to all submissions
More information3/8/2018. Reasons for Doing UDT. UDT: A Tool in Risk Assessment. Faculty/Presenter Disclosure. Urine Drug Testing in Chronic Pain Management
Urine Drug Testing in Chronic Pain Management March 8, 2018 Faculty/Presenter Disclosure Faculty: Andrew J Smith, MDCM Relationships with commercial interests: None to report Andrew J Smith, MDCM Staff
More informationProcedure for Toxicology Analysis Version 4 Toxicology Unit Effective Date: 05/10/2013. Toxicology Analysis
Toxicology Analysis 1.0 Purpose - This procedure specifies the required elements for analyzing toxicology submissions and reporting the results of the analysis. 2.0 Scope This procedure applies to all
More informationGuidelines on Autopsy Practice: Scenario 3: Suspected illicit drugs
Guidelines on Autopsy Practice: Scenario 3: Suspected illicit drugs Updates made August 2005 1. Pathology encountered: causes of death re-ordered, with addition of chronic alcohol ketoalcoholic syndrome
More informationA substance that reduces pain and may or may not have psychoactive properties.
GLOSSARY OF TERMS AMPHETAMINE-TYPE STIMULANTS (ATS) A group of substances, mostly synthetic, with closely related chemical structure which have, to varying degrees, a stimulating effect on the central
More informationADMINISTRATION OF JUSTICE FORENSIC TOXICOLOGY
I. INTRODUCTION ADMINISTRATION OF JUSTICE FORENSIC TOXICOLOGY A. Toxicology is concerned with the chemical and physical properties of toxic substances, their physiological effects on living organisms and
More informationUrine Drug Testing to Monitor Opioid Use In Managing Chronic Pain
Faculty Disclosure Henry C. Nipper, PhD, DABCC Dr. Nipper has listed no financial interest/arrangement that would be considered a conflict of interest. Urine Drug Testing to Monitor Opioid Use In Managing
More informationDrug Overdose Fatality Surveillance System (DOFSS) 2015 Annual Report
Drug Overdose Fatality Surveillance System (DOFSS) 05 Annual Report Released: October 07 Sarah L. Hargrove, MS Patrick J. Ward, MPH Terry L. Bunn, PhD Kentucky Injury Prevention and Research Center, bona
More informationThe Drug Evaluation and Classification Program
The Drug Evaluation and Classification Program International Association of Chiefs of Police Drug Evaluation and Classification (DEC) Program The Drug Evaluation and Classification (DEC) Program is a transportation
More informationOverview of the AACC Academy s LMPG: Using clinical laboratory tests to monitor drug therapy in pain management patients
Overview of the AACC Academy s LMPG: Using clinical laboratory tests to monitor drug therapy in pain management patients Gwen McMillin, PhD, DABCC(CC,TC) Professor, University of Utah Medical Director,
More informationUrine Drug Testing Methods 3-5
Urine Drug Testing Methods 3-5 Type of Test Logistics Pearls Initial Screening Test: Immunoassay Confirmatory Test: Gas chromatography-mass spectrometry (GCMS) + or Liquid chromatography-mass spectrometry
More informationTest Definition: PCDSO Pain Clinic Drug Screen, Urine
Reporting Title: Pain Clinic Drug Screen, U Performing Location: Rochester Specimen Requirements: Collection Container/Tube: Plastic urine container Submission Container/Tube: Plastic, 60-mL urine bottle
More informationToxicology aspects of SUDI. Dr Stephen Morley STH
Toxicology aspects of SUDI Dr Stephen Morley STH Epidemiology of SUDI toxicology Neonatal-placental transfer Breast milk 3 rd person administration Association between illicit drug use in pregnancy and
More informationNARCOTIC NOTES FLIPBOOK BY: PER:
NARCOTIC NOTES FLIPBOOK BY: PER: 1 https://www.youtube. com/watch?v=lolb21bii-a 2 Laws, Collection, & Preservation Narcotic Drugs = natural or synthetic substance that produces bodily (physiological) or
More informationGold Standard for Urine Drug Testin Urine Drug Testing Why U rine? Urine?
Gold Standard for Urine Drug Testing Developed by TRMC Pain Management Center Jill Duffy, RN,BC Pam Kennell, RN, BC Heidi Beisch, RN Urine Drug Testing A DIAGNOSTIC tool For an OBJECTIVE test Based on
More informationBLOOD SCIENCES DEPARTMENT OF CLINICAL BIOCHEMISTRY. 2. Sample collection and requesting procedure for toxicology analysis
Authoriser: Peter Beresford Page 1 of 5 For the most up-to-date version of this document please view the online version at: https://www.nbt.nhs.uk/severn-pathology/pathology-services/clinical-biochemistry/toxicology
More informationPayment Policy: Urine Specimen Validity Testing Reference Number: CC.PP.056 Product Types: ALL Effective Date: 11/01/2017 Last Review Date:
Payment Policy: Reference Number: CC.PP.056 Product Types: ALL Effective Date: 11/01/2017 Last Review Date: Coding Implications Revision Log See Important Reminder at the end of this policy for important
More informationINVOLVEMENT OF DRUGS IN ACCIDENT CAUSATION
INVOLVEMENT OF DRUGS IN ACCIDENT CAUSATION Jim GEROSTAMOULOS, Helen BATZIRIS, Olaf H. DRUMMER Victorian Institute of Forensic Medicine and Department of Forensic Medicine, Monash University, Southbank,
More informationDrug Screening: Things You Need to Know
Drug Screening: Things You Need to Know (a view inside the clinical laboratory) Gary L. Horowitz, MD Director, Clinical Chemistry, Beth Israel Deaconess Medical Center Associate Professor of Pathology,
More informationForensic Toxicology. William C. Bress, PhD State Toxicologist Adjunct Assistant Professor Department of Biology University of Vermont
Forensic Toxicology William C. Bress, PhD State Toxicologist Adjunct Assistant Professor Department of Biology University of Vermont History of Forensic Toxicology Paracelsus (1493-1541) 1541) Orfila (1787-1853)
More informationJen L. Schroeder, B.S.
PO Box 20590 Boulder, Colorado 80308 5375 Western Avenue Boulder, Colorado 80301 (303) 440-4500 Fax (303) 440-0668 www.chematox.com EDUCATION Jen L. Schroeder, B.S. Western Kentucky University, Bowling
More informationTest Definition: PDSOX Pain Clinic Drug Screen, Chain of Custody, Urine
Reporting Title: Pain Clinic Drug Screen, CoC, U Performing Location: Rochester Specimen Requirements: Container/Tube: Chain-of-Custody Kit (Supply T282) containing the specimen containers, seals, and
More informationNational Drug-Related Deaths Index
HRB Bulletin Drug Deaths 2015 National Drug-Related Deaths Index 2004 to 2015 data Overview This update presents figures from the National Drug- Related Deaths Index (NDRDI) on deaths due to poisoning
More informationACUTE & CHRONIC ETHANOL EFFECTS An Overview
ACUTE & CHRONIC ETHANOL EFFECTS An Overview University of Papua New Guinea School of Medicine & Health Sciences, Division of Basic Medical Sciences Clinical Biochemistry: PBL Seminar MBBS Yr 4 VJ Temple
More informationLaboratory Service Report
4 05/25/19 Client C702884-DLP ROCHESTER Amphetamines, Confirmation Positive Confirmed POSITIVE by LC-S/S for the following: Amphetamine = 52 ethamphetamine = 124 ethamphetamine exists in the d- and l-isomeric
More informationPatient-Centered Urine Drug Testing. Douglas Gourlay, MD, MSc, FRCPC, FASAM
Patient-Centered Urine Drug Testing Douglas Gourlay, MD, MSc, FRCPC, FASAM Declaration of Potential Conflict of Interest The content of this presentation is non- commercial and does not represent any conflict
More informationUNIVERSITY OF PNG SCHOOL OF MEDICINE AND HEALTH SCIENCES DIVISION OF BASIC MEDICAL SCIENCES Discipline of Biochemistry and Molecular Biology
UNIVERSITY OF PNG SCHOOL OF MEDICINE AND HEALTH SCIENCES DIVISION OF BASIC MEDICAL SCIENCES Discipline of Biochemistry and Molecular Biology 1 PBL SEMINAR ACUTE & CHRONIC ETHANOL EFFECTS An Overview Sites
More informationFrequently Asked Questions: Opiate Dependency and Methadone Maintenance Treatment program follow-up
Frequently Asked Questions: Opiate Dependency and Methadone Maintenance Treatment program follow-up Dr. Bhushan M. Kapur Associate Professor Department of Laboratory Medicine and Pathobiology, Faculty
More informationFigure 1. National Drug Overdose Deaths Number Among All Ages, by Gender,
Figure 1. National Drug Overdose Deaths Number Among All Ages, by Gender, -217 1, Total Overdose Deaths Male Female 8, 7,237 6, 4, 16,849 2 21 22 23 24 36,1 25 26 27 28 29 21 211 212 213 214 215 216 217-217
More informationUsing Liquid Chromatography Tandem Mass Spectrometry Urine Drug Testing to Identify Licit and Illicit Drug-Use in a Community-based Patient Population
Using Liquid Chromatography Tandem Mass Spectrometry Urine Drug Testing to Identify Licit and Illicit Drug-Use in a Community-based Patient Population Adam S. Ptolemy 1, Colleen Murray 2, Edward Dunn 3,
More informationMEDICAL POLICY Drug Testing
POLICY: PG0069 ORIGINAL EFFECTIVE: 01/01/11 LAST REVIEW: 11/13/18 MEDICAL POLICY Drug Testing GUIDELINES This policy does not certify benefits or authorization of benefits, which is designated by each
More informationEDUCATIONAL COMMENTARY METHADONE
EDUCATIONAL COMMENTARY METHADONE Educational commentary is provided through our affiliation with the American Society for Clinical Pathology (ASCP). To obtain FREE CME/CMLE credits see the Continuing Education
More informationSchedule of Accreditation
Schedule of Accreditation Organisation Name Trading As INAB Reg No Contact Name Address Medical Bureau Of Road Safety 30T Helen Kearns Contact Phone No 01-7165555 Email Website Accreditation Standard Health
More informationSeptember HCMC Toxicology Transition: Additional information and Frequently Asked Questions
September 2016 HCMC Toxicology Transition: Additional information and Frequently Asked Questions Many clinicians have asked for more information about the Urine Drug Compliance Analysis (LAB8742) switch
More informationDetection of Drugs-of-Abuse by Tandem Mass Spectrometry.
Detection of Drugs-of-Abuse by Tandem Mass Spectrometry. Dr Tim Laurens MSc.Chem(Pretoria), Ph.D. Chem (Pretoria), MSc.Toxicology (Surrey,UK) FRSChem, MFSSoc Email: laurensj@lancet.co.za / tim.laurens@up.ac.za
More informationConflict of Interest Disclosure
Patient Rx Drug Misuse and Abuse: Compliance Toxicology Monitoring in Clinical Practice Toxicology Staff Andrea Terrell, Ph.D., DABCC Chief Scientific Officer George Behonick, Ph.D., DABFT, Manager, FBU
More informationThe Drug Testing Process. Employer or Practice
Disclosures Clinical Professor, Jefferson Medical College BOD MROCC [Medical Review Officer Certification Council] BOD National Sleep Foundation BOD POEMS [Pennsylvania Occupational & Environmental Medicine
More informationTests that have had changes to the method/ CPT code, units of measurement, scope of analysis, reference comments, or specimen requirements.
In our continuing effort to provide you with the highest quality toxicology laboratory services available, we have compiled important changes regarding a number of tests we perform. Listed below are the
More informationWELCOME! 12/13/2018. Today s Topic: Urine Drug Screens in OUD Treatment UW PACC
Psychiatry and Addictions Case Conference UW Medicine Psychiatry and Behavioral Sciences 12/13/2018 WELCOME! Today s Topic: Urine Drug Screens in OUD Treatment Should I test and how should I do drug testing
More informationNational Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCE Narrative
National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCE Narrative The SCE Narrative is written by the Sentinel Community Epidemiologist (SCE) and provides
More informationPAIN & ANALGESIA. often accompanied by clinical depression. fibromyalgia, chronic fatigue, etc. COX 1, COX 2, and COX 3 (a variant of COX 1)
Pain - subjective experience associated with detection of tissue damage ( nociception ) acute - serves as a warning chronic - nociception gone bad often accompanied by clinical depression fibromyalgia,
More informationFATAL POISONINGS BY MEDICINAL OPIOIDS IN FINLAND
FATAL POISONINGS BY MEDICINAL OPIOIDS IN FINLAND ERKKI VUORI 12.-13.11.2012 HJELT INSTITUUTTI OIKEUSLÄÄKETIETEEN OSASTO FINLAND IS AN IDEAL COUNTRY FOR POST- MORTEM TOXICOLOGICAL INVESTIGATIONS High autopsy
More informationMEDICAL POLICY No R2 DRUG TESTING
Summary of Changes MEDICAL POLICY DRUG TESTING Effective Date: April 10, 2017 Review Dates: 5/15, 5/16, 11/16, 2/17 Date Of Origin: May 13, 2015 Status: Current Clarifications: Deletions: Additions: Pg.
More informationCOUNTY OF SAN DIEGO. Opioid Update
COUNTY OF SAN DIEGO Opioid Update Linda Bridgeman Smith, DUI & Prevention Services Manager Health & Human Services Agency, Behavioral Health Services Co-chair, Prescription Drug Abuse Task Force 1 HEADLINES
More informationIdentification of Specific Drugs and Drug Diversion in Drug Overdose Fatalities
Identification of Specific Drugs and Drug Diversion in Drug Overdose Fatalities Svetla Slavova, PhD Sara LaMantia, MS Terry Bunn, PhD Tracey Corey, MD 2016 Safe States Annual Meeting April 13, 2016, Albuquerque,
More informationClaire Gilbert, Tony Margetts, Gilda Nunez, Bryony Sedgwick, Tim Allison. Thanks to Hull Public Health, Prof. Marks and Paul Smith
There is something in the heroin: responding to a rise in drug related deaths and the emergence of fentanyl and carfentanil in a local illicit drug market Claire Gilbert, Tony Margetts, Gilda Nunez, Bryony
More informationDRUG TESTING POLICY. Policy Number: ADMINISTRATIVE T0 Effective Date: October 1, Related Policies None
DRUG TESTING POLICY UnitedHealthcare Oxford Reimbursement Policy Policy Number: ADMINISTRATIVE 259.1 T0 Effective Date: October 1, 2017 Table of Contents Page INSTRUCTIONS FOR USE... 1 APPLICABLE LINES
More informationB. To assess an individual when clinical evaluation suggests use of non-prescribed medications or illegal substances; or
Integrated Reference #: MP/D010 Page: 1 of 7 PRODUCT APPLICATION: PreferredOne Community Health Plan (PCHP) PreferredOne Administrative Services, Inc. (PAS) ERISA PreferredOne Administrative Services,
More informationControlled Substance Monitoring in the Age of the Opioid Epidemic
Controlled Substance Monitoring in the Age of the Opioid Epidemic Paul E. Hilliard, MS, MD Hospital Pain Committee Chair Department of Anesthesiology CME housekeeping I have no financial disclosures AKA,
More informationMedical Affairs Policy
Medical Affairs Policy Service: Urine Drug/Alcohol Screening and Testing PUM 250-0013-1803 Medical Policy Committee Approval 03/06/18 Effective Date 07/01/18 Prior Authorization Needed No Disclaimer: This
More informationDRUG TESTING POLICY. Policy Number: ADMINISTRATIVE T0 Effective Date: March 1, Related Policies None
DRUG TESTING POLICY UnitedHealthcare Oxford Reimbursement Policy Policy Number: ADMINISTRATIVE 259.3 T0 Effective Date: March 1, 2018 Table of Contents Page INSTRUCTIONS FOR USE... 1 APPLICABLE LINES OF
More informationMEDICAL POLICY Drug Testing
POLICY: PG0069 ORIGINAL EFFECTIVE: 01/01/11 LAST REVIEW: 04/10/18 MEDICAL POLICY Drug Testing GUIDELINES This policy does not certify benefits or authorization of benefits, which is designated by each
More informationApplications of High Resolution Mass Spectrometry in Forensic Toxicology. Patrick Kyle, PhD.
Applications of High Resolution Mass Spectrometry in Forensic Toxicology Patrick Kyle, PhD pkyle@umc.edu Financial Disclosures Grant/Research Support: None Salary/Consultant Fees: None Board/Committee/Advisory
More informationDRUG TESTING POLICY. Policy Number: ADMINISTRATIVE T0 Effective Date: January 1, Related Policies None
DRUG TESTING POLICY UnitedHealthcare Oxford Reimbursement Policy Policy Number: ADMINISTRATIVE 259.2 T0 Effective Date: January 1, 2018 Table of Contents Page INSTRUCTIONS FOR USE... 1 APPLICABLE LINES
More informationToxicology 101. Arizona Problem Solving Courts April 25, 2016
Toxicology 101 Arizona Problem Solving Courts April 25, 2016 Aaron Brown, Ph.D. Technical Group Lead Norchem Drug Testing Laboratory Cordant Health Solutions Flagstaff, Arizona Toxicology Toxicology is
More informationINTOXICATION DEATHS ASSOCIATED WITH DRUGS OF ABUSE OR ALCOHOL BALTIMORE CITY
2009 FINAL REPORT INTOXICATION DEATHS ASSOCIATED WITH DRUGS OF ABUSE OR ALCOHOL BALTIMORE CITY This report was prepared by: Dr. Jose Arbelaez, M.D. of Baltimore Substance Abuse Systems, and Ryan J. Petteway,
More informationOpioids: Use, Abuse and Cause of Death. Jennifer Harmon Assistant Director - Forensic Chemistry Orange County Crime Laboratory
Opioids: Use, Abuse and Cause of Death Jennifer Harmon Assistant Director - Forensic Chemistry Orange County Crime Laboratory jharmon@occl.ocgov.com Opioid: Any psychoactive chemical that resembles morphine
More informationTest Name Results Units Bio. Ref. Interval
135091312 Age 30 Years Gender Male 15/9/2017 122400M 15/9/2017 11729M 19/9/2017 40644M Ref By Final Test Results Units Bio. Ref. Interval DRUGS OF ABUSE, URINE AMHETAMINE SCREEN, URINE results indicate
More informationFastect II Drug Screen Dipstick Test Training and Certification Program
Fastect II Drug Screen Dipstick Test Training and Certification Program Fastect II Training Page 1 of 7 Rev. B Fastect II Drug Screen Dipstick Test Training and Certification for Test Administrators The
More informationCommunity Drug Early Warning System (CDEWS-3): Washington, DC - Site 3 of 4
Community Drug Early Warning System (CDEWS-3): Washington, DC - Site 3 of 4 Office of National Drug Control Policy Executive Office of the President May 2017 ACKNOWLEDGMENTS This report was funded by Cooperative
More informationEvaluation of the Impact of Expanding ELISA Screening in DUID Investigations. Aileen Lu*, Karen S. Scott, Aya Chan-Hosokawa, and Barry K.
Evaluation of the Impact of Expanding ELISA Screening in DUID Investigations Aileen Lu*, Karen S. Scott, Aya Chan-Hosokawa, and Barry K. Logan FSF Emerging Forensic Scientist Award Oral Presentation Disclosure
More informationDrug Testing: How to Evaluate Results
Drug Testing: How to Evaluate Results Prepared for you by the West Virginia Drug Testing Laboratory Drug testing, whether for an individual or a large corporation, consists of two necessary steps - specimen
More informationOxymorphone Distribution in Biological Matrices: A Collection of Case Studies
Oxymorphone Distribution in Biological Matrices: A Collection of Case Studies Brian Simons, Forensic Toxicologist Montgomery County Coroner s Office / Miami Valley Regional Crime Laboratory May 1, 2008
More informationINTOXICATION DEATHS ASSOCIATED WITH DRUGS OF ABUSE OR ALCOHOL BALTIMORE, MARYLAND QUARTERLY REPORT: SECOND QUARTER, 2008
INTOXICATION DEATHS ASSOCIATED WITH DRUGS OF ABUSE OR ALCOHOL BALTIMORE, MARYLAND QUARTERLY REPORT: SECOND QUARTER, 28 A report from the Office of Epidemiology and Planning Baltimore City Health Department
More informationWelcome! Supreme Court of Ohio Specialized Dockets Conference. October 23-24, 2017
Welcome! Supreme Court of Ohio Specialized Dockets Conference October 23-24, 2017 Drug Testing: Do you know enough to be dangerous? Presented by William L. Parker President & CEO American Court & Drug
More informationControlled Substance Monitoring and Drugs of Abuse Testing Determination
CPT s: 80305 Drug test(s), presumptive, any number of drug classes, any number of devices or procedures (eg, immunoassay); capable of being read by direct optical observation only (eg, dipsticks, cups,
More informationRapid Spot Tests for Detecting the Presence of Adulterants in Urine Specimens Submitted for Drug Testing
Clinical Chemistry / SPOT TESTS TO DETECT ADULTERANTS IN URINE SPECIMENS Rapid Spot Tests for Detecting the Presence of Adulterants in Urine Specimens Submitted for Drug Testing Amitava Dasgupta, PhD,
More informationFentanyl Postmortem Redistribution: Preliminary Findings Regarding the Relationship Among Femoral Blood and Liver and Heart Tissue Concentrations
Fentanyl Postmortem Redistribution: Preliminary Findings Regarding the Relationship Among Femoral Blood and Liver and Heart Tissue Concentrations Kristin Luckenbill 1,2, Jonathan Thompson 3, Owen Middleton
More informationToxicological Investigation of Drug Impaired Driving Toxicology Laboratory Survey
Toxicological Investigation of Drug Impaired Driving Toxicology Laboratory Survey Kayla J. Lowrie, MS, Jennifer Turri, BS, Jill Yeakel, MSFS, Barry K. Logan, PhD, DABFT, Arcadia University, 450 S. Easton
More informationDrug Testing Policy. Reimbursement Policy CMS Approved By. Policy Number. Annual Approval Date. Reimbursement Policy Oversight Committee
Reimbursement Policy CMS 1500 Drug Testing Policy Policy Number 2018R6005A Annual Approval Date 07/11/2018 Approved By Reimbursement Policy Oversight Committee IMPORTANT NOTE ABOUT THIS REIMBURSEMENT POLICY
More information2017 Drug Screen Tests
2017 Drug Screen Tests The ABCs of Applying the CMS 2017 HCPCS Codes Written by: Karen D. Chappell, EJD, MBA, CIRCC, CPMA, CPC-I, CHC Terminology Immunoassay Qualitative Therapeutic Quantitative GC/MS
More informationDane County Oral Fluid Pilot Project- Establishing an Oral Fluid Drug Testing Program in Alabama
Dane County Oral Fluid Pilot Project- Establishing an Oral Fluid Drug Testing Program in Alabama Curt Harper, Ph.D., F-ABFT Alabama Department of Forensic Sciences Candace Lightner, Founder and President
More informationBeating Drug Tests and Defending Positive Results
Beating Drug Tests and Defending Positive Results Amitava Dasgupta Beating Drug Tests and Defending Positive Results A Toxicologist s Perspective Amitava Dasgupta Department of Pathology and Laboratory
More informationInvestigation of Propofol in Post- Mortem and Ante-Mortem Specimens by GC/MS
Investigation of Propofol in Post- Mortem and Ante-Mortem Specimens by GC/MS Mike Frontz, Robert Rodriguez, Gary Kunsman Bexar County Medical Examiner s Office, San Antonio, TX Brad Hall, Patricia Schroeder,
More informationAgonists: morphine, fentanyl Agonists-Antagonists: nalbuphine Antagonists: naloxone
Opioid Definition All drugs, natural or synthetic, that bind to opiate receptors Agonists: morphine, fentanyl Agonists-Antagonists: nalbuphine Antagonists: naloxone Opioid agonists increase pain threshold
More informationPostmortem Redistribution of Fentanyl in Blood
Clinical Chemistry / Postmortem Redistribution of Fentanyl Postmortem Redistribution of Fentanyl in Blood Kalen N. Olson, PhD, 1 Kristin Luckenbill, PhD, JD, 1 Jonathan Thompson, MD, 2 Owen Middleton,
More informationWhat is pregabalin? Pregabalin tablets. Pregabalin misuse. National Drug Treatment Centre Research. Administration
What is pregabalin? Pregabalin is a prescription drug used to manage a number of long-term conditions, including epilepsy, neuropathic pain and generalised anxiety disorder. Similar to benzodiazepines,
More informationOption D: Drugs and Medicines. Workbook
IB Chemistry SL/HL Option D: Drugs and Medicines D1. Pharmaceutical products Workbook 1. List three effects that drugs or medicines have on the functioning of the body. a) b) c) 2. What is meant by natural
More informationFluids. There are 32 body fluids that may be found at a crime scene
Fluids& Toxicology Fluids There are 32 body fluids that may be found at a crime scene Some of them include amniotic fluid, bile, cerebrospinal fluid, mucus, perspiration, phlegm, saliva, semen, tears,
More informationPain Management and Compliance Toxicology. Greg Jellick, MSFS, D-ABFT-FT Technical Director Quality Toxicology San Antonio, TX
Pain Management and Compliance Toxicology Greg Jellick, MSFS, D-ABFT-FT Technical Director Quality Toxicology San Antonio, TX Prescription Drug Abuse: A National Problem Prescription drug abuse is a growing
More informationThe Utility of Urine Drug Screening
The Utility of Urine Drug Screening Treating Addiction, Saving Lives Sea Cruises Bye Tazmania, still far from New Zealand February 8 th, 2018 Mandy Manak, MD FASAM, ISAM, CSAM, MRO Medical Director, ICDO
More information